Interview

Senior Care
Interview

What’s Exciting in Translational Cancer Research, According to Katie Sloan, Investor at Cancer Research Horizons.

Cancer survival rates in the UK have doubled over the past 50 years due to advancements in early diagnosis and treatment, with Cancer Research UK (CRUK) playing a key role by funding nearly £400 million in research annually. In an interview with Katie Sloan, an investment manager at Cancer Research Horizons, we highlight CRH's efforts in accelerating oncology innovation, including supporting early-stage ventures like Trogenix, which is developing a novel gene therapy platform targeting aggressive cancers such as glioblastoma, with promising preclinical results and planned clinical trials in 2025.

Lucy Ahern

April 3, 2025

Senior Care
Interview

Forge Genetics’ Next Milestone Is Strategic Partnerships

Genetic engineering is a fast-paced field and biotech Forge Genetics, offers a unique technology called Forge Editing, to catapult the industry further. We have covered Forge Genetics in a previous Start-up Spotlight, where you can read a more in-depth summary of their background. But here we will discuss Forge Genetics' vision for the future and how they look to tackle their upcoming challenges.

Ariyana Rayatt

December 13, 2024

Our latest updates. In your inbox. Once a month.

Sign up for our monthly newsletter of upcoming events, recently published insights and SEC updates.